Intrinsic Value of S&P & Nasdaq Contact Us

SAB Biotherapeutics, Inc. SABS NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
56/100
2/6 Pass
SharesGrow Intrinsic Value
$5.59
+38%
Analyst Price Target
$7.00
+72.8%

SAB Biotherapeutics, Inc. (SABS) has 20 known insider and institutional holders on record. The largest holder is Reich Samuel J with 4,800,000 shares. Other notable holders include Big Cypress Holdings LLC and Sullivan Eddie Joe.

Over the last 12 months, insiders have made 27 transactions in SABS stock — 20 buys (valued at $145.49M) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

SABS Insider Ownership

Top Holder
Reich Samuel J
4,800,000 shares
Buys (12 mo)
20
$145.49M value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 74%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Reich Samuel J CEO 4,800,000 2026-02-05
100%
2 Big Cypress Holdings Llc 10 Percent Owner, Officer: CEO and CFO 3,047,825 2021-01-14
63%
3 Sullivan Eddie Joe President 3,000,000 2026-02-05
63%
4 To Lucy See Remarks 2,400,000 2026-02-05
50%
5 Bausch Christoph Lawrence Chief Operating Officer 1,800,000 2026-02-05
38%
6 Beyer Russell P Chief Financial Officer 275,000 2023-03-16
6%
7 Jain Rita Director 240,000 2026-01-07
5%
8 Zaccardelli David Director 240,000 2026-01-07
5%
9 Moin Andrew Director 211,100 2025-10-01
4%
10 Sessa Capital (master), L.p. Director 211,100 2025-10-01
4%
11 Giberson Scott Director 150,000 2025-12-18
3%
12 Ellias Helen K. Director 150,000 2025-12-18
3%
13 Link David Director 150,000 2025-12-18
3%
14 Polvino William James Director 150,000 2025-12-18
3%
15 Lucera Erick Director 150,000 2025-12-18
3%
16 Skyler Jay S Director 150,000 2025-12-18
3%
17 King Michael Chief Financial Officer 115,000 2024-02-23
2%
18 Kropotova Alexandra Chief Medical Officer 43,296 2026-03-25
1%
19 Finnegan Frederick Chief Business Officer 23,453 2022-03-18
0%
20 Luke Thomas Charles Chief Medical Officer 20,519 2022-03-18
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-24 Kropotova Alexandra Chief Medical Officer Tax Withholding of RSU 988 - -
2026-02-03 To Lucy See Remarks RSU Award 2,400,000 $4.45 $10.68M
2026-02-03 Bausch Christoph Lawrence Chief Operating Officer RSU Award 1,800,000 $4.45 $8.01M
2026-02-03 Sullivan Eddie Joe President RSU Award 3,000,000 $4.45 $13.35M
2026-02-03 Kropotova Alexandra Chief Medical Officer RSU Award 2,400,000 $4.45 $10.68M
2026-02-03 Reich Samuel J CEO RSU Award 4,800,000 $4.45 $21.36M
2026-01-05 Jain Rita Director RSU Award 240,000 $3.74 $897.6K
2026-01-05 Jain Rita Officer Unknown - - -
2026-01-05 Zaccardelli David Director RSU Award 240,000 $3.74 $897.6K
2026-01-05 Zaccardelli David Officer Unknown - - -
2025-12-16 Link David Director RSU Award 150,000 $3.99 $598.5K
2025-12-16 Ellias Helen K. Director RSU Award 150,000 $3.99 $598.5K
2025-12-16 Giberson Scott Director RSU Award 150,000 $3.99 $598.5K
2025-12-16 Polvino William James Director RSU Award 150,000 $3.99 $598.5K
2025-12-16 Lucera Erick Director RSU Award 150,000 $3.99 $598.5K
2025-12-16 Skyler Jay S Director RSU Award 150,000 $3.99 $598.5K
2025-12-11 Kropotova Alexandra Chief Medical Officer Tax Withholding of RSU 988 - -
2025-09-29 Moin Andrew Director Option Exercise (Sell) 17,400 $1.75 $30.45K
2025-09-29 Sessa Capital (master), L.p. Director Option Exercise (Sell) 17,400 $1.75 $30.45K
2025-09-19 Kropotova Alexandra Chief Medical Officer Tax Withholding of RSU 1,977 - -
2025-08-26 To Lucy See Remarks RSU Award 1,200,000 $2.17 $2.6M
2025-08-26 Bausch Christoph Lawrence Chief Operating Officer RSU Award 600,000 $2.17 $1.3M
2025-08-26 Sullivan Eddie Joe President RSU Award 3,000,000 $2.17 $6.51M
2025-08-26 Kropotova Alexandra Chief Medical Officer RSU Award 2,400,000 $2.17 $5.21M
2025-08-26 Reich Samuel J CEO & Executive Chairman RSU Award 4,800,000 $2.17 $10.42M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message